Shattuck Labs/$STTK
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Shattuck Labs
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
Ticker
$STTK
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
44
Website
Shattuck Labs Metrics
BasicAdvanced
$36M
-
-$1.39
1.64
-
Price and volume
Market cap
$36M
Beta
1.64
52-week high
$4.00
52-week low
$0.69
Average daily volume
373K
Financial strength
Current ratio
9.078
Quick ratio
8.325
Long term debt to equity
3.353
Total debt to equity
4.724
Profitability
EBITDA (TTM)
-70.899
Gross margin (TTM)
131.50%
Net profit margin (TTM)
-1,532.96%
Operating margin (TTM)
-1,621.58%
Revenue per employee (TTM)
$100,000
Management effectiveness
Return on assets (TTM)
-41.77%
Return on equity (TTM)
-71.90%
Valuation
Price to revenue (TTM)
8.409
Price to book
0.54
Price to tangible book (TTM)
0.54
Price to free cash flow (TTM)
-0.686
Free cash flow yield (TTM)
-145.73%
Free cash flow per share (TTM)
-1.11
Growth
Revenue change (TTM)
69.65%
Earnings per share change (TTM)
-27.17%
3-year revenue growth (CAGR)
-45.04%
3-year earnings per share growth (CAGR)
0.50%
What the Analysts think about Shattuck Labs
Analyst ratings (Buy, Hold, Sell) for Shattuck Labs stock.
Shattuck Labs Financial Performance
Revenues and expenses
Shattuck Labs Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Shattuck Labs stock?
Shattuck Labs (STTK) has a market cap of $36M as of August 01, 2025.
What is the P/E ratio for Shattuck Labs stock?
The price to earnings (P/E) ratio for Shattuck Labs (STTK) stock is 0 as of August 01, 2025.
Does Shattuck Labs stock pay dividends?
No, Shattuck Labs (STTK) stock does not pay dividends to its shareholders as of August 01, 2025.
When is the next Shattuck Labs dividend payment date?
Shattuck Labs (STTK) stock does not pay dividends to its shareholders.
What is the beta indicator for Shattuck Labs?
Shattuck Labs (STTK) has a beta rating of 1.64. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.